Targeting follicular helper CD4 T cells in SLE

靶向 SLE 中的滤泡辅助 CD4 T 细胞

基本信息

  • 批准号:
    10063844
  • 负责人:
  • 金额:
    $ 38.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-12-01 至 2022-07-17
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract This proposal intends to characterize Tfh cells, a population that is critical for disease development and maintenance in SLE and test the novel hypothesis that SLE-Tfh are uniquely sensitive to metabolic inhibition, a feature that can be exploited to therapeutic intervention. The scientific premise of this proposal is based on three lines of evidence: 1. The necessary role of Tfh cells for the production of pathogenic autoAbs in lupus has been well-established in SLE patients and mouse models; 2. Tfh cells induced by immunization are metabolically quiescent, a fact that we have confirmed showing that they are not affected by glucose inhibitors in lupus-prone and control mice; and 3. We have strong preliminary data showing that SLE-Tfh cells from four different mouse models of lupus are sensitive to glucose. We propose the hypothesis that spontaneous Tfh cells supporting the production of autoAbs (SLE-Tfh) have a different metabolism than Tfh cells providing protective humoral immunity against pathogens (TD-Tfh) in either lupus or normal mice. Based on similarities of CD4+ T cell functions and metabolism in lupus-prone mice and SLE patients, we also hypothesize that the expanded Tfh cells in SLE patients also have a different metabolism than that of health controls (HCs). Consequently, we predict that targeting Tfh cellular metabolism provides an effective approach to treat lupus without compromising the patients’ protection against TD- pathogens. We propose to test these hypotheses using cellular and molecular immunology approaches in mouse models as well as with human PBLs with the three following specific aims 1. To define the molecular and metabolic signatures of SLE-Tfh as compared to TD-Tfh cells elicited by TD-dependent Ags (PR8 flu virus and NP-OVA) in lupus mice and B6 controls. The immunophenotypes, anatomical location, gene expression, and metabolic profile of spontaneous Tfh cells in TC and B6.lpr mice will be compared to that of flu-specific I-A(b) NP-tetramer positive Tfh cells in TC, B6.lpr and B6 mice infected with PR8 virus. In addition to these polyclonal T cell models, we will use an adoptive transfer model of OVA-specific OT-II T cells carrying the Sle1 lupus susceptibility allele that favors the expansion of Tfh cells (9) into NP-OVA immunized mice (10). This aim will define the functional differences between TD-Tfh and SLE-Tfh cells in two models of lupus and with two different TD-immunizations. 2. To define the response of SLE-Tfh and TD-Tfh cells to glucose inhibition in the mouse. Using the same experimental systems as in SA1, we will compare the responses of SLE-Tfh cells and TD-Tfh cells to glucose inhibition in mice treated with 2DG, a glucose analog that blocks the first reaction of glycolysis. 3. To compare the molecular and metabolic signatures of circulating cTfh cells in SLE patients and HCs, as well as their response to metformin. We hypothesize that the expansion of cTfh cells in SLE patients is largely driven by autoAgs, and that SLE-cTfh cells share functional signatures with murine SLE-Tfh cells. On the other hand, cTfh cells from HCs have been largely induced by TD-Ags, and HC-cTfh cells should overlap with murine TD-Tfh cells. We will compare the immunophenotypes and gene expression of these two types of Tfh cells, as well as their response to the metabolic inhibitor metformin in vitro. Our first goal is to advance our understanding of SLE-Tfh cells, and ultimately to advance the treatment of lupus, based on discrete, achievable goals focusing on one cell population. This project will advance our understanding of disease mechanisms, and yield results with a high translational potential.
项目总结/文摘

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TLR7 Activation Accelerates Cardiovascular Pathology in a Mouse Model of Lupus.
  • DOI:
    10.3389/fimmu.2022.914468
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Elshikha AS;Teng XY;Kanda N;Li W;Choi SC;Abboud G;Terrell M;Fredenburg K;Morel L
  • 通讯作者:
    Morel L
Metabolic regulation of follicular helper T cell differentiation in a mouse model of lupus.
狼疮小鼠模型中滤泡辅助 T 细胞分化的代谢调节。
  • DOI:
    10.1016/j.imlet.2022.03.008
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Zou,Xueyang;Choi,Seung-Chul;Zeumer-Spataro,Leilani;Scindia,Yogesh;Moser,EmilyK;Morel,Laurence
  • 通讯作者:
    Morel,Laurence
Promise and complexity of lupus mouse models.
  • DOI:
    10.1038/s41590-021-00914-4
  • 发表时间:
    2021-06
  • 期刊:
  • 影响因子:
    30.5
  • 作者:
    Moore E;Reynolds JA;Davidson A;Gallucci S;Morel L;Rao DA;Young HA;Putterman C
  • 通讯作者:
    Putterman C
Redox homeostasis involvement in the pharmacological effects of metformin in systemic lupus erythematosus.
  • DOI:
    10.1089/ars.2021.0070
  • 发表时间:
    2021-10
  • 期刊:
  • 影响因子:
    6.6
  • 作者:
    X. Teng;Josephine Brown;L. Morel
  • 通讯作者:
    X. Teng;Josephine Brown;L. Morel
Pharmacologically Inferred Glycolysis and Glutaminolysis Requirement of B Cells in Lupus-Prone Mice.
  • DOI:
    10.4049/jimmunol.2100356
  • 发表时间:
    2022-05-01
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Choi, Seung-Chul;Li, Wei;Zhang, Xiaojuan;Kanda, Nathalie;Zeumer-Spataro, Leilani;Teng, Xiangyu;Morel, Laurence
  • 通讯作者:
    Morel, Laurence
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laurence Morel其他文献

Laurence Morel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laurence Morel', 18)}}的其他基金

Targeting ferroptosis in renal tubular epithelial cells to improve outcomes of lupus nephritis
靶向肾小管上皮细胞铁死亡以改善狼疮性肾炎的预后
  • 批准号:
    10638468
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Determinants of follicular helper T cell expansion in lupus
狼疮滤泡辅助 T 细胞扩张的决定因素
  • 批准号:
    10644534
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
Determinants of follicular helper T cell expansion in lupus
狼疮滤泡辅助 T 细胞扩张的决定因素
  • 批准号:
    10679012
  • 财政年份:
    2022
  • 资助金额:
    $ 38.13万
  • 项目类别:
Determinants of follicular helper T cell expansion in lupus
狼疮滤泡辅助 T 细胞扩张的决定因素
  • 批准号:
    10065726
  • 财政年份:
    2020
  • 资助金额:
    $ 38.13万
  • 项目类别:
Determinants of follicular helper T cell expansion in lupus
狼疮滤泡辅助 T 细胞扩张的决定因素
  • 批准号:
    10212953
  • 财政年份:
    2020
  • 资助金额:
    $ 38.13万
  • 项目类别:
Gut dysbiosis and tryptophan metabolism in lupus
狼疮中的肠道菌群失调和色氨酸代谢
  • 批准号:
    10079461
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Gut dysbiosis and tryptophan metabolism in lupus
狼疮中的肠道菌群失调和色氨酸代谢
  • 批准号:
    10543063
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Gut dysbiosis and tryptophan metabolism in lupus
狼疮中的肠道菌群失调和色氨酸代谢
  • 批准号:
    10321633
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Gut dysbiosis and tryptophan metabolism in lupus
狼疮中的肠道菌群失调和色氨酸代谢
  • 批准号:
    10675349
  • 财政年份:
    2019
  • 资助金额:
    $ 38.13万
  • 项目类别:
Gut dysbiosis induces lupus
肠道菌群失调诱发狼疮
  • 批准号:
    9199844
  • 财政年份:
    2016
  • 资助金额:
    $ 38.13万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 38.13万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了